Balchem Corporation  

(Public, NASDAQ:BCPC)   Watch this stock  
Find more results for BCPC
-1.62 (-2.97%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 52.85 - 54.74
52 week 48.89 - 69.92
Open 54.07
Vol / Avg. 173,973.00/211,429.00
Mkt cap 1.63B
P/E 37.03
Div/yield 0.30/0.57
EPS 1.43
Shares 30.70M
Beta 0.90
Inst. own 83%
Feb 25, 2015
Q4 2014 Balchem Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 10, 2014
Q3 2014 Balchem Corp Earnings Call
Nov 10, 2014
Q3 2014 Balchem Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 9.46% 13.31%
Operating margin 15.75% 19.46%
EBITD margin - 22.56%
Return on average assets 6.99% 13.02%
Return on average equity 16.61% 14.85%
Employees 387 -
CDP Score - -


P O Box 600
United States - Map
+1-845-3265632 (Phone)
+1-845-3265742 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Balchem Corporation is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in three segments. The Company's Specialty Products segment operates in industry as ARC Specialty Products. The SensoryEffects segment supplies ingredients in the food and beverage industry; providing customized solutions in powder and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides the animal nutrition market with nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Company operates two domestic subsidiaries which are wholly-owned, BCP Ingredients, Inc. (BCP) and Aberco, Inc. (Aberco). It also operates two wholly owned subsidiaries in Europe: Balchem BV and Balchem Italia Srl.

Officers and directors

Dino A. Rossi Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William A. Backus CPA Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
David F. Ludwig Vice President, General Manager- Specialty Products, Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Francis J. Fitzpatrick CPA Vice President - Administration
Age: 53
Bio & Compensation  - Reuters
Matthew D. Houston General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
John Y. Televantos Ph.D. Lead Independent Director
Bio & Compensation  - Reuters
Paul D. Coombs Independent Director
Age: 58
Bio & Compensation  - Reuters
David B. Fischer Independent Director
Age: 51
Bio & Compensation  - Reuters
Edward L. McMillan Independent Director
Age: 68
Bio & Compensation  - Reuters
Perry W. Premdas Independent Director
Age: 61
Bio & Compensation  - Reuters